𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of a 10-Gy boost in the conservation treatment of early breast cancer: results of a randomized clinical trial in Lyon, France

✍ Scribed by P. Romestaing; Y. Lehingue; D. Delaunay; C. Carrie

Book ID
108434430
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
27 KB
Volume
51
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Eighteen-year results in the treatment o
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy : The National Cancer Institute randomized trial
✍ Matthew M. Poggi; David N. Danforth; Linda C. Sciuto; Sharon L. Smith; Seth M. S πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Between 1979–1987, the National Cancer Institute conducted a randomized, prospective study of mastectomy (MT) versus breast conservation therapy (BCT) in the treatment of patients with early‐stage breast carcinoma. After a median potential follow‐up of 18.4 years, the aut

A prospective randomized trial of doxoru
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer
✍ Massimo Lopez; Alma Contegiacomo; Patrizia Vici; Concetta Dello Ioio; Luigi Di L πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 481 KB πŸ‘ 2 views

Seventy-six patients with advanced breast cancer were entered into the current study. They were randomized to receive either idarubicin (IDA) 45 mg/m2 orally or doxorubicin (DX) 75 mg/m2 intravenously (IV), both drugs being administered every 3 weeks. Among 37 evaluable patients who received DX trea